Tuesday, January 04, 2011

China: An Emerging Market for Cancer Therapeutics

Date Posted: 12/30/2010
Size: 6.12MB
Length: 00:13:48
Thought Leader: Richard Wagner, Ph.D., Senior Director, Kantar Health
In this episode, Dr. Wagner talks about China as an emerging market for cancer drugs, including the differences between the U.S. and China in terms of access to testing and drugs, as well as differences in healthcare coverage. We'll also discuss some of Kantar's latest research on cancer in China.

Download transcript and white paper

For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.